The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots. Category: UncategorisedBy 8 April 2021Leave a commentPost navigationPreviousPrevious post:Promotional material: COVID-19 vaccination: what to expect after vaccinationNextNext post:Independent report: UK NSC ethical considerations in the restoration of adult screening pathways